These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17021097)

  • 1. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.
    Hesselink AT; Bulkmans NW; Berkhof J; Lorincz AT; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2006 Oct; 44(10):3680-5. PubMed ID: 17021097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
    Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
    J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
    Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
    Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia.
    Gustavsson I; Juko-Pecirep I; Backlund I; Wilander E; Gyllensten U
    J Clin Virol; 2009 Jun; 45(2):85-9. PubMed ID: 19451022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.
    Seme K; Fujs K; Kocjan BJ; Poljak M
    J Virol Methods; 2006 Jun; 134(1-2):252-6. PubMed ID: 16417931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
    Eder PS; Lou J; Huff J; Macioszek J
    J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.
    Klug SJ; Molijn A; Schopp B; Holz B; Iftner A; Quint W; J F Snijders P; Petry KU; Krüger Kjaer S; Munk C; Iftner T
    J Med Virol; 2008 Jul; 80(7):1264-74. PubMed ID: 18461626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP.
    Nazarenko I; Kobayashi L; Giles J; Fishman C; Chen G; Lorincz A
    J Virol Methods; 2008 Dec; 154(1-2):76-81. PubMed ID: 18835300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
    Castle PE; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Wacholder S; Burk RD; Manos MM; Schussler JE; Macomber P; Schiffman M
    J Clin Microbiol; 2003 Sep; 41(9):4022-30. PubMed ID: 12958220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
    Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Smith JS
    Gynecol Oncol; 2012 Apr; 125(1):175-80. PubMed ID: 22233689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of high-risk HPV types by the hybrid capture 2 test.
    Terry G; Ho L; Londesborough P; Cuzick J; Mielzynska-Lohnas I; Lorincz A
    J Med Virol; 2001 Sep; 65(1):155-62. PubMed ID: 11505458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of accuracy of three assays for human papillomavirus detection and typing: Hybrid Capture 2, HPV Consensus kit and Amplicor HPV].
    Hantz S; Caly H; Decroisette E; Dutrop A; Bakeland D; Pascal B; Darreye G; Dussartre C; Renaudie J; Rogez S; Aubard Y; Denis F; Alain S
    Pathol Biol (Paris); 2008 Feb; 56(1):29-35. PubMed ID: 18178026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.